产品报价：180000元
更新时间：2014/11/9 22:24:41
产地：英国
品牌：proimmune
型号：FXXX
厂商性质： 生产型,
公司名称： 上海宾智生物科技有限公司
黄韬 : (15021864318) (13611743570)
（联系我时，请说明是在来宝网上看到的，谢谢！）ALLELE | PEPTIDE CODE | PEPTIDE SEQUENCE | Stock/ | EPITOPE ORIGIN |
A*01:01 | 686 | TDLGQNLLY | A | Adenovirus 5 Hexon 886-894 |
A*24:02 | 684 | TYFSLNNKF | A | Adenovirus 5 Hexon 37-45 |
B*07:02 | 989 | KPYSGTAYNAL | A | Adenovirus Hexon 114-124 |
ALLELE | PEPTIDE CODE | PEPTIDE SEQUENCE | Stock/ | EPITOPE ORIGIN |
A*02:01 | 151 | KLQVFLIVL | A | T1D Diabetes human prepro islet amyloid polypeptide ppIAPP 5-13 |
A*02:01 | 954 | LNIDLLWSV | A | T1D Diabetes IGRP 228–236 |
A*02:01 | 851 | HLVEALYLV | A | Insulin B chain 10-18 |
A*02:01 | 393 | VMNILLQYV | A | GAD65 114-122 |
A*02:01 | 470 | SLSRFSWGA | A | Myelin basic protein 110-118 |
A*02:01 | 1904 | VLFGLGFAI | A | T1D Diabetes IGRP 265-273 |
(back to top)
ALLELE | PEPTIDE CODE | PEPTIDE SEQUENCE | Stock/ | EPITOPE ORIGIN |
A*01:01 | 307 | KSDICTDEY | A | Tyrosinase 243-251 (244S) |
A*02:01 | 2291 | AILALLPAL | A | Prostate Stem Cell Antigen (PSCA) 105-133 |
A*02:01 | 1920 | ALLTSRLRFI | A | Telomerase Reverse Transcriptase (hTRT) 615-624 |
A*02:01 | 2083 | FLAEDALNTV | A | Epithelial Discoidin Domain Receptor 1 (EDDR1) 867-876 |
A*02:01 | 2079 | FLYDDNQRV | A | Topoisomerase II-alpha-b 828-836 |
A*02:01 | 1386 | GLAPPQHLIRV | A | p53 187-197 |
A*02:01 | 468 | ILSLELMKL | A | Receptor for hyaluronic acid–mediated |
A*02:01 | 1464 | LTLGEFLKL | A | Survivin-3A 96-104 |
A*02:01 | 2299 | SLPPPGTRV | A | p53 149-157 |
A*02:01 | 1403 | VIMPCSWWV | A | Chondromodulin-I 319-327 |
A*02:01 | 1201 | YMCSFLFNL | A | Ewing Tumor EZH2 666-674 |
A*02:01 | 061 | YMDGTMSQV | A | Tyrosinase 369-377 (371D) |
A*02:01 | 447 | YLQVNSLQTV | A | Telomerase Reverse Transcriptase (hTRT) 988-997 |
A*02:01 | 859 | KLQDASAEV | A | HM1.24-aa 126-134 |
A*02:01 | 329 | ILLWQPIPV | A | Prostatic Acid Phosphatase-3 (PAP-3) 135-143 |
A*02:01 | 560 | GLMEEMSAL | A | Human Mena protein (overexpressed in breast cancer) |
A*02:01 | 813 | FVGEFFTDV | A | GPC3 144-152 (overexpressed in hepatocellular carcinoma) |
A*02:01 | 075 | YLSGANLNL | S | Carcinogenic Embryonic Antigen (CEA) 571-579 |
A*02:01 | 157 | VLYRYGSFSV | A | gp100 (pmel17) 476-485 |
A*02:01 | 250 | VLQELNVTV | S | Leukocyte Proteinase-3 (Wegener's autoantigen) 169-177 |
A*02:01 | 097 | VISNDVCAQV | A | Prostate Specific Antigen-1 (PSA-1) 154-163 |
A*02:01 | 390 | SLLMWITQV | A | NY-ESO-1 157-165 |
A*02:01 | 212 | RLLQETELV | S | HER-2/neu 689-697 |
A*02:01 | 810 | LIAHNQVRQV | A | HER-2/neu 85–94 |
A*02:01 | 690 | LLHETDSAV | A | PSMA/PSM-P1 4-12 |
A*02:01 | 599 | ALDVYNGLL | A | Prostatic acid phosphatase precursor (PAP) 299-307 |
A*02:01 | 645 | YLNTVQPTCV | A | EGF-R 1138-1147 |
A*02:01 | 781 | VLDGLDVLL | A | PRAME 100-108 |
A*02:01 | 689 | VLAGGFFLL | A | PSMA 27-38 |
A*02:01 | 394 | YLFFYRKSV | A | mTERT 572-580 |
A*02:01 | 034 | FLWGPRALV | A | MAGEA3 271-279 |
A*02:01 | 646 | KLFGTSGQKT | A | EGF-R-479 350-359 |
A*02:01 | 915 | TLPGYPPHV | A | PAX-5 311-319 |
A*02:01 | 1056 | SLFLGILSV | A | CD20 188-196 (B cell malignancies) |
A*02:01 | 117 | RLVDDFLLV | A | Telomerase Reverse Transcriptase 865-873 |
A*02:01 | 208 | LLLLTVLTV | A | MUC-1 12-20 |
A*02:01 | 205 | LLGRNSFEV | A | p53 264-272 |
A*02:01 | 600 | ALFDIESKV | A | PSM P2 (prostate) |
A*02:01 | 1013 | FLGYLILGV | A | Prostatic Acid Phosphatase-3 (PAP-3) |
A*02:01 | 561 | TMNGSKSPV | A | hMena 502-510 |
A*02:01 | 391 | LMLGEFLKL | S | Survivin 96-104 |
A*02:01 | 338 | QLCPICRAPV | A | Livin/ML-IAP280 175-184 |
A*02:01 | 1181 | SLSEKTVLL | A | CD59 glycoprotein precursor 106-114 |
A*02:01 | 958 | SLVDVMPWL | A | Cytochrome p450 1B1 239-248 |
A*02:01 | 214 | KIFGSLAFL | A | HER-2/neu 369-377 |
A*02:01 | 046 | IMDQVPFSV | S | gp100 (pmel17) 209-217 |
A*02:01 | 210 | ILHNGAYSL | A | HER-2/neu 435-443 |
A*02:01 | 085 | ILAKFLHWL | S | Telomerase 540-548 |
A*02:01 | 249 | HLSTAFARV | A | G250 (renal cell carcinoma) 217-225 |
A*02:01 | 125 | GVLVGVALI | A | Carcinogenic Embryonic Antigen (CEA) 694-702 |
A*02:01 | 527 | ALYVDSLFFL | A | PRAME PRA 300–309 |
A*02:01 | 405 | KLQCVDLHV | A | Prostate Specific Antigen 146-154 |
A*02:01 | 086 | ALQPGTALL | A | Prostate Stem Cell Antigen (PSCA) 14-22 |
A*02:01 | 302 | KVAELVHFL | A | MAGEA3 112-120 |
A*02:01 | 057 | KTWGQYWQV | A | gp100 (pmel17) 154-162 |
A*02:01 | 389 | GLYDGMEHL | A | MAGEA-10 254-262 |
A*02:01 | 404 | FLTPKKLQCV | A | Prostate Specific Antigen-1 (PSA-1) 141-150 |
A*02:01 | 082 | ELAGIGILTV | s | MelanA / MART 26-35 |
A*02:01 | 171 | KVLEYVIKV | A | MAGEA1 278-286 |
A*02:01 | 2293 | GLQHWVPEL | A | BA46 (Lactadherin) 97-106 |
A*02:01 | 2294 | GVRGRVEEI | A | bcr-abl fusion protein |
A*02:01 | 048 | YLSGADLNL | A | Carcinoembryonic antigen (CEA)-derived peptide CAP1-6D |
A*02:01 | 2296 | ITDQVPFSV | A | gp100 (pmel) 209-217 |
A*02:01 | 047 | YLEPGPVTV | A | gp100 (pmel) 280-288 (288V) |
A*02:01 | 2301 | YLQLVFGIEV | A | MAGEA2 157-166 |
A*02:01 | 2298 | KVAEELVHFL | A | MAGEA3 112-120 (alternative version) |
A*02:01 | 049 | SLLMWITQC | A | NY-ESO-1 157-165 (9C) |
A*02:01 | 2300 | YLGSYGFRL | A | p53 103-111 |
A*02:01 | 2297 | KLCPVQLWV | A | p53 139-147 |
A*02:01 | 654 | RMPEAAPPV | A | p53 65-73 |
A*02:01 | 1787 | RLTSRVKAL | A | Telomerare Reverse Transcriptase (hTRT) 653-661 |
A*02:01 | 1786 | GLLGASVLGL | A | Telomerase Reverse Transcriptase (hTRT) 674-683 |
A*02:01 | 381 | LLLTVLTVV | A | Tumor Mucin Antigen 13-21 |
A*03:01 | 118 | ALLAVGATK | A | gp100 (pmel17) 17-25 |
A*03:01 | 264 | ATGFKQSSK | A | bcr-abl 210 kD fusion protein 259-269 |
A*03:01 | 087 | KQSSKALQR | S | bcr-abl 210 kD fusion protein 21-29 |
A*03:01 | 541 | RISTFKNWPK | A | Survivin-3A 18-27 (27K) |
A*24:02 | 416 | EYLQLVFGI | A | MAGEA2 156-164 |
A*24:02 | 421 | TFPDLESEF | A | MAGEA3 97-105 |
A*24:02 | 209 | TYACFVSNL | A | Carcinogenic Embryonic Antigen (CEA) 652-660 |
A*24:02 | 417 | TYLPTNASL | A | HER-2/neu 63-71 |
A*24:02 | 418 | VYGFVRACL | A | Telomerase reverse transcriptase (hTRT) 461-469 |
A*24:02 | 230 | AFLPWHRLF | A | Tyrosinase 188-196 |
A*24:02 | 2303 | CYASGWGSI | A | Prostate Specific Antigen-1 153-161 |
A*24:02 | 238 | VYFFLPDHL | A | gp100-intron 4 170-178 |
A*24:02 | 1806 | RYCNLEGPPI | A | Lymphocyte antigen 6 complex locus K (LY6K) 177-186 |
A*24:02 | 2302 | AYACNTSTL | A | Survivin 80-88 |
B*07:02 | 2304 | LPWHRLFLL | A | Tyrosinase 208-216 |
B*08:01 | 094 | GFKQSSKAL | A | bcr-abl 210 kD fusion protein 19-27 |
B*35:01 | 2307 | MPFATPMEA | A | NY-ESO-1 94-102 |
H-2 Db | 1731 | ATFKNWPFL | A | Murine Survivin 20-28 |
H-2Db | 695 | Abu-Abu-L-Abu-LTVFL | A | Moloney murine sarcoma virus (MoMSV) GagL 85–93 |
H-2Db | 2199 | FSNSTNDILI | A | VEGFR2/KDR fragment 1 614-624 |
H-2Db | 1333 | KVPRNQDWL | A | gp100 (pmel17) 25-33 |
H-2Kb | 185 | SVYDFFVWL | A | Tyrosinase related protein-2 180-188 |
H-2Kb | 351 | HNTQYCNL | A | MAGEA5 5-12 |
H-2Kb | 2311 | TVSEFLKL | A | Murine Survivin 97-104 |
H-2Kd | 0275 | DYWGQGTEL | A | Surface IgG (sA20-Ig) of A20 106-114 |
H-2Kd | 814 | EYILSLEEL | A | GPC3 298-306 |
H-2Kd | 343 | TYVPANASL | A | neu/HER-2/Erbb2 proto-oncoprotein 66-74 |
H-2Ld | 150 | LPYLGWLVF | A | Tumour Antigen P815 35-43 |
(back to top)
ALLELE | PEPTIDE CODE | PEPTIDE SEQUENCE | Stock/ | EPITOPE ORIGIN |
A*02:01 | 334 | RLNMFTPYI | A | Chlamydia trachomatis MOMP 258-266 |
(back to top)
ALLELE | PEPTIDE CODE | PEPTIDE SEQUENCE | Stock/ | EPITOPE ORIGIN |
A*01:01 | 739 | VTEHDTLLY | A | HCMV pp50 245-253 |
A*01:01 | 266 | YSEHPTFTSQY | A | HCMV pp65 363-373 |
A*02:01 | 1598 | VLAELVKQI | A | HCMV IE1 81-89 |
A*02:01 | 008 | NLVPMVATV | S | HCMV pp65 495-504 |
A*03:01 | 1599 | KLGGALQAK | A | HCMV IE1 184-192 |
A*24:02 | 414 | QYDPVAALF | A | HCMV pp65 341-349 |
A*24:02 | 380 | VYALPLKML | A | HCMV pp65 113-121 |
B*07:02 | 045 | TPRVTGGGAM | S | HCMV pp65 417-426 |
B*07:02 | 308 | RPHERNGFTVL | A | HCMV pp65 265-275 |
B*08:01 | 691 | QIKVRVDMV | A | HCMV IE1 88-96 |
B*35:01 | 114 | IPSINVHHY | A | HCMV pp65 123-131 |
H-2Db | 2313 | HGIRNASFI | A | MCMV m45 985-993 |
H-2Dd | 278 | AGPPRYSRI | A | MCMV m164 257-265 |
H-2Ld | 021 | YPHFMPTNL | S | MCMV IE1 168-176 |
(back to top)
ALLELE | PEPTIDE CODE | PEPTIDE SEQUENCE | Stock/ | EPITOPE ORIGIN |
A*02:01 | 666 | FLYALALLL | A | EBV LMP-2 356-364 |
A*02:01 | 001 | GLCTLVAML | S | EBV BMLF-1 259-267 |
A*02:01 | 042 | CLGGLLTMV | S | EBV LMP-2 426-434 |
A*02:01 | 409 | YLLEMLWRL | A | EBV LMP-1 125-133 |
A*02:01 | 2292 | FLDKGTYTL | A | EBV BALF-4 276–284 |
A*03:01 | 727 | RLRAEAQVK | A | ENV EBNA 3A 603–611 |
A*11:01 | 639 | ATIGTAMYK | A | EBV BRLF1 134-142 |
A*11:01 | 199 | IVTDFSVIK | A | EBV EBNA-4 416-424 |
A*11:01 | 508 | SSCSSCPLSK | A | EBV LMP-2 340-349 |
A*24:02 | 648 | PYLFWLAAI | A | EBV LMP2 131-139 |
A*24:02 | 683 | TYGPVFMSL | A | EBV LMP2 419–427 |
A*24:02 | 420 | TYGPVFMCL | A | EBV LMP-2 419-427 |
B*07:02 | 044 | RPPIFIRRL | S | EBV EBNA-3A 247-255 |
B*07:02 | 2305 | QPRAPIRPI | A | EBV EBNA-3C 881-889 |
B*08:01 | 190 | RAKFKQLL | S | EBV BZLF-1 190-197 |
B*08:01 | 073 | FLRGRAYGL | S | EBV EBNA-3A 193-201 |
B*08:01 | 489 | QAKWRLQTL | A | EBV EBNA3A 158-166 |
B*35:01 | 387 | HPVGEADYFEY | A | EBV EBNA-1 407-417 |
B*35:01 | 399 | EPLPQGQLTAY | A | EBV BZLF-1 54-64 |
B*40:01 | 692 | IEDPPFNSL | A | EBV LMP2 200-208 |
(back to top)
ALLELE | PEPTIDE CODE | PEPTIDE SEQUENCE | Stock/ | EPITOPE ORIGIN |
A*02:01 | 032 | FLLSLGIHL | S | HBV polymerase 573-581 |
A*02:01 | 027 | FLLTRILTI | S | HBV envelope 183-191 |
A*02:01 | 023 | FLPSDFFPSV | S | HBV core antigen 18-27 |
A*02:01 | 028 | GLSPTVWLSV | A | HBV surface antigen 185-194 |
A*02:01 | 031 | WLSLLVPFV | S | HBV surface antigen 172-181 |
A*02:01 | 283 | FLPSDFFPSI | A | HBV core 18-27 (subtype ADR4) |
A*11:01 | 377 | YVNVNMGLK | A | HBV core antigen 88-96 |
A*24:02 | 413 | KYTSFPWLL | A | HBV polymerase 756-764 |
A*24:02 | 378 | EYLVSFGVW | A | HBV core 117-125 |
H-2Kb | 422 | ILSPFLPLL | A | HBV surface antigen 208-216 |
H-2Kb | 1431 | MGLKFRQL | A | HBV core 93-100 |
H-2Kb | 477 | VWLSVIWM | A | HBV Surface antigen 190-197 |
H-2Ld | 129 | IPQSLDSWWTSL | S | HBV surface antigen 28-39 |
(back to top)
ALLELE | PEPTIDE CODE | PEPTIDE SEQUENCE | Stock/ | EPITOPE ORIGIN |
A*01:01 | 1066 | ATDALMTGF | A | HCV NS3 1436-1444 |
A*01:01 | 740 | ATDALMTGY | A | HCV NS3 1435-1443 |
A*02:01 | 036 | VLSDFKTWL | A | HCV NS5a 1987-1995 |
A*02:01 | 172 | LLFNILGGWV | A | HCV NS4b 1807-1816 |
A*02:01 | 242 | KLSGLGINAV | A | HCV NS3 1406-1415 |
A*02:01 | 1094 | GLQDCTMLV | A | HCV NS5B 2727-2735 |
A*02:01 | 003 | CINGVCWTV | A | HCV NS3 1073-1081 |
A*02:01 | 004 | YLLPRRGPRL | A | HCV core 35-44 |
A*02:01 | 002 | DLMGYIPAV | S | HCV core 132-140 |
A*02:01 | 491 | DLMGYIPLV | A | HCV core 132-140 |
A*02:01 | 040 | KLVALGINAV | A | HCV NS3 1406-1415 |
A*02:01 | 858 | CVNGVCWTV | A | HCV NS3 1073-1081 |
A*02:01 | 037 | ALYDVVTKL | A | HCV NS5b 2594-2602 |
A*03:01 | 035 | RVCEKMALY | A | HCV NS5B 2588-2596 |
A*24:02 | 415 | AYSQQTRGL | A | HCV NS3 1031-1039 |
B*07:02 | 845 | DPRRRSRNL | A | HCV core 111-119 |
B*07:02 | 742 | GPRLGVRAT | A | HCV core 41-49 |
B*08:01 | 721 | HSKKKCDEL | A | HCV NS3 1395-1403 |
B*35:01 | 565 | HPNIEEVAL | A | HCV NS3 1359-1367 |
B*35:01 | 942 | CPNSSIVY | A | HCV E1 207-214 |
B*40:01 | 939 | REISVPAEIL | A | HCV NS5a 2266-2275 |
H-2Db | 791 | GAVQNEVTL | A | HCV NS3 1629-1637 |
(back to top)
ALLELE | PEPTIDE CODE | PEPTIDE SEQUENCE | Stock/ | EPITOPE ORIGIN |
A*02:01 | 430 | GLADQLIHL | A | HIV-1 Vif 101-109 |
A*02:01 | 799 | LTFGWCFKL | A | HIV-1 Nef 137-145 |
A*02:01 | 084 | ILKEPVHGV | S | HIV-1 RT 476-484 |
A*02:01 | 246 | KLTPLCVTL | A | HIV-1 env gp120 90-98 |
A*02:01 | 010 | SLYNTVATL | S | HIV-1 gag p17 76-84 |
A*02:01 | 174 | TLNAWVKVV | A | HIV-1 gag p24 19-27 |
A*03:01 | 194 | RLRPGGKKK | S | HIV-1 gag p17 19-27 |
A*03:01 | 109 | QVPLRPMTYK | S | HIV-1 nef 73-82 |
A*24:02 | 419 | RYLKDQQLL | A | HIV-1 gag gp41 67-75 |
A*24:02 | 411 | RYPLTFGWCY | A | HIV-1 Nef 134-143 |
B*07:02 | 257 | TPGPGVRYPL | S | HIV-1 nef 128-137 |
B*07:02 | 196 | IPRRIRQGL | A | HIV-1 env gp120 848-856 |
B*07:02 | 877 | GPGHKARVL | A | HIV gag p24 223–231 |
B*08:01 | 193 | FLKEKGGL | S | HIV-1 nef 90-97 |
B*08:01 | 195 | GEIYKRWII | A | HIV-1 gag p24 261-269 |
B*15:01 | 1072 | RLRPGGKKKY | A | HIV-1 p17 20-29 |
B*27:05 | 294 | KRWIILGLNK | A | HIV-1 gag p24 265-274 |
B*27:05 | 874 | KRWIIMGLNK | A | HIV-1 gag p24 263-272 |
B*27:05 | 2306 | GRAFVTIGK | A | HIV-1 gp100 103-111 |
B*35:01 | 255 | NPDIVIYQY | A | HIV-1 RT 328-336 |
B*35:01 | 1211 | VPLDEDFRKY | A | HIV-1 RT 273-282 |
B*40:01 | 840 | KEKGGLEGL | A | HIV-1 Nef 92-100 |
H-2Dd | 177 | RGPGRAFVTI | A | HIV-1 IIIB gp120 318-327 |
H-2Dd | 1684 | IGPGRAFYA | A | HIV-1 US4 gp120 318-326 |
H-2Kd | 176 | AMQMLKETI | A | HIV-1 gag p24 199-207 |
(back to top)
ALLELE | PEPTIDE CODE | PEPTIDE SEQUENCE | Stock/ | EPITOPE ORIGIN |
A*02:01 | 095 | YMLDLQPETT | S | HPV 16 E7 11-20 |
A*02:01 | 2312 | MLDLQPETT | A | HPV 16 E7 12-20 |
A*03:01 | 2064 | KLCLRFLSK | A | HPV 33 E6 64-72 |
B*07:02 | 2065 | KPTLKEYVL | A | HPV 33 E7 5-13 |
H-2Db | 502H | RAHYNIVTF | A | HPV 16 E7 49-57 |
(back to top)
ALLELE | PEPTIDE CODE | PEPTIDE SEQUENCE | Stock/ | EPITOPE ORIGIN |
A*02:01 | 200 | LLFGYPVYV | A | Human T-cell lymphotropic virus-1 Tax 11-19 |
A*02:01 | 2309 | AVLDGLLSL | A | HTLV bZIP factor 42-50 |
A*24:02 | 1043 | SFHSLHLLF | A | Human T-cell lymphotropic virus-1 Tax 301-309 |
(back to top)
ALLELE | PEPTIDE CODE | PEPTIDE SEQUENCE | Stock/ | EPITOPE ORIGIN |
A*01:01 | 076 | CTELKLSDY | A | Influenza A (PR8) NP 44-52 |
A*01:01 | 540 | VSDGGPNLY | A | Influenza A PB1 591-599 |
A*02:01 | 007 | GILGFVFTL | S | Influenza A MP 58-66 |
A*02:01 | 2295 | ILGFVFTLTV | A | Influenza A MP 59-68 |
A*03:01 | 77 | ILRGSVAHK | A | Influenza A (PR8) NP 265-274 |
A*11:01 | 1513 | SIIPSGPLK | A | Influenza A MP 13-21 |
A*11:01 | 1720 | RMVLASTTAK | A | Influenza A MP1 178-187 |
A*11:01 | 1722 | KSMREEYRK | A | Influenza A MP2 70-78 |
B*07:02 | 1744 | SPIVPSFDM | A | Influenza A NP 473-481 |
B*07:02 | 1743 | QPEWFRNVL | A | Influenza A PB1 329-337 |
B*27:05 | 463 | SRYWAIRTR | A | Influenza A NP 383-391 |
H-2Db | 119 | ASNENMETM | S | Influenza A (PR8) NP 366-374 |
H-2Db | 009 | ASNENMDAM | S | Influenza A (NT60) NP 366-374 |
H-2Db | 120 | SSLENFRAYV | A | Influenza A (PR8) Polymerase acidic protein 224-233 |
H-2Kd | 098 | TYQRTRALV | S | Influenza A (PR8) NP 147-155 |
H-2Kd | 240 | IYSTVASSL | A | Influenza A HA 533-541 |
(back to top)
ALLELE | PEPTIDE CODE | PEPTIDE SEQUENCE | Stock/ | EPITOPE ORIGIN |
A*02:01 | 2308 | ALPHIIDEV | A | LCMV envelope gp 10-18 |
A*02:01 | 2310 | YLVSIFLHL | A | LCMV envelope gp 447-455 |
H-2Db | 070 | FQPQNGQFI | S | LCMV NP 396-404 |
H-2Db | 069 | KAVYNFATC | S | LCMV GP1 33-41 |
H-2Db | 186 | SGVENPGGYCL | A | LCMV GP 276-286 |
H-2 Kb | 2076 | ISHNFCNL | A | LCMV GP 118-125 |
(back to top)
ALLELE | PEPTIDE CODE | PEPTIDE SEQUENCE | Stock/ | EPITOPE ORIGIN |
H-2Kd | 178 | GYKDGNEYI | A | Listeria monocytogenes Listeriolysin 91-99 |
(back to top)
ALLELE | PEPTIDE CODE | PEPTIDE SEQUENCE | Stock/ | EPITOPE ORIGIN |
A*02:01 | 314 | YLNKIQNSL | A | Plasmodium falciparum CSP 334-342 |
H-2Kd | 771 | YYIPHQSSL | A | Plasmodium falciparum Liver stage antigen 1671-1679 |
H-2Kd | 376 | SYIPSAEKI | A | Plasmodium berghei CSP 252-260 |
(back to top)
ALLELE | PEPTIDE CODE | PEPTIDE SEQUENCE | Stock/ | EPITOPE ORIGIN |
A*02:01 | 581 | RTLDKVLEV | A | miHAg HA-8 |
A*02:01 | 175 | FIDSYICQV | A | miHAg H-Y (human SMCY) 311-319 |
A*02:01 | 473 | VLHDDLLEA | A | miHAg HA-1 137-145 |
B*07:02 | 1113 | SPSVDKARAEL | A | miHAg SMCY 1041-1051 |
H-2Db | 328 | KCSRNRQYL | A | miHAg SMCY 738-746 |
H-2Db | 327 | WMHHNMDLI | S | miHAg UTY 246-254 |
(back to top)
ALLELE | PEPTIDE CODE | PEPTIDE SEQUENCE | Stock/ | EPITOPE ORIGIN |
H-2Kb | 093 | SIINFEKL | S | Ovalbumin 257-264 |
H-2Kb | 908 | KVVRFDKL | A | Ovalbumin (subdominant) 55-62 |
H-2Kb | 562 | LTFNYRNL | A | Histocompatibility antigen 60 39-46 |
H-2Kb | 1803 | SIYRYYGL | A | Synthetic variant of VSV Nucleoprotein 498–505 |
H-2Kd | 198 | HYLSTQSAL | A | Enhanced Green Fluorescent Protein (eGFP) 200-208 |
H-2Ld | 074 | TPHPARIGL | S | E. coli beta-galactosidase 876-884 |
(back to top)
ALLELE | PEPTIDE CODE | PEPTIDE SEQUENCE | Stock/ | EPITOPE ORIGIN |
A*02:01 | N01 | NEGATIVE | S | Negative Control |
(back to top)
ALLELE | PEPTIDE CODE | PEPTIDE SEQUENCE | Stock/ | EPITOPE ORIGIN |
A*02:01 | 366 | LMWYELSKI | A | KSHVF-8 gB.492-500 |
A*02:01 | 773 | VLPLTVAEV | A | Mesothelin 530–538 |
A*02:01 | 1152 | VLMIKALEL | A | Non muscle Myosin-9 741-749 |
A*02:01 | 353 | RILGAVAKV | A | Vinculin 822-830 |
A*02:01 | 133 | LLDVPTAAV | A | Interferon gamma inducible protein (GILT) 30 27-35 |
A*02:01 | 1153 | QLFNHTMFI | A | Non-muscle Myosin 478-486 |
E*01:01 | 712 | VMAPRTLIL | A | HLA-C leader sequence peptide |
H-2Kb | 188 | SSIEFARL | A | HSV-1 gp B 498-505 |
H-2Kb | 828 | KSPWFTTL | A | MuLV env 622-629 |
H-2Kb | 488 | VVYDFLKL | A | SV40 T antigen 404-411 |
H-2Kd | 062 | RYLKNGKETL | A | HLA-Cw3 170-179 |
H-2Kd | 458 | KYNKANVFL | A | NRP-V7 superagonist peptide 8.3 Tg NOD mouse |
H-2Ld | 398 | SPSYVYHQF | A | MuLV env gp70 423-431 |
(back to top)
ALLELE | PEPTIDE CODE | PEPTIDE SEQUENCE | Stock/ | EPITOPE ORIGIN |
A*02:01 | 801 | KMLKEMGEV | A | RSV NP 137-145 |
H-2Kd | 154 | SYIGSINNI | A | RSV M2 82-90 |
H-2Kd | 149 | KYKNAVTEL | A | RSV A strain F protein 85-93 |
(back to top)
ALLELE | PEPTIDE CODE | PEPTIDE SEQUENCE | Stock/ | EPITOPE ORIGIN |
H-2Kb | 056 | FAPGNYPAL | S | Sendai virus NP 324-332 |
(back to top)
ALLELE | PEPTIDE CODE | PEPTIDE SEQUENCE | Stock/ | EPITOPE ORIGIN |
Mamu-A*01 | 1110 | CTPYDINQM | A | SIV Gag 181-189 |
Mamu-A*02 | 1111 | YTSGPGIRY | A | SIV Nef 159-167 |
Mamu-A*02 | 1112 | GSENLKSLY | A | SIV Gag 71-79 |
(back to top)
ALLELE | PEPTIDE CODE | PEPTIDE SEQUENCE | Stock/ | EPITOPE ORIGIN |
H-2Kb | 964 | VNHRFTLV | A | Trypanosoma cruzi ASP-2 553-560 |
H-2Kb | 708 | ANYNFTLV | A | Trypanosoma cruzi SP 536-543 |
(back to top)
ALLELE | PEPTIDE CODE | PEPTIDE SEQUENCE | Stock/ | EPITOPE ORIGIN |
A*02:01 | 324 | GLPVEYLQV | A | Mycobacterium bovis antigen 85-A 6-14 |
A*02:01 | 276 | KLIANNTRV | A | Mycobacterium bovis antigen 85-A 200-208 |
H-2Db | 547 | AIQGNVTSI | A | Mycobacterium tuberculosis ESAT-6 17-25 |
H-2Kb | 769 | IMYNYPAML | A | Mycobacterium tuberculosisTB10.4 4-12 |
H-2Kb | 764 | IMYNYPAM | A | Mycobacterium tuberculosisTB10.4 4-11 |
H-2Ld | 158 | MPVGGQSSF | A | Mycobacterium tuberculosis Ag85A 70–78 |
(back to top)
ALLELE | PEPTIDE CODE | PEPTIDE SEQUENCE | Stock/ | EPITOPE ORIGIN |
A*02:01 | 978 | ILDDNLYKV | A | Vaccinia virus Copenhagen Protein G5 18-26 |
A*02:01 | 703 | KVDDTFYYV | A | Vaccinia virus Host range protein 2 74-82 |
H-2Kb | 733 | TSYKFESV | A | Vaccinia virus WR epitope B8R 20-27 |
(back to top)
ALLELE | PEPTIDE CODE | PEPTIDE SEQUENCE | Stock/ | EPITOPE ORIGIN |
H-2Kb | 373 | RGYVYQGL | A | VSV NP 52 |
H-2Ld | 622 | MPYLIDFGL | A | VSV N 275-283 |
(back to top)
ALLELE | PEPTIDE CODE | PEPTIDE SEQUENCE | Stock/ | EPITOPE ORIGIN |
A*02:01 | 1320 | RLDDDGNFQL | A | West Nile Virus NY-99 polyprotein precursor (1452-1461) |
A*02:01 | 1327 | YTMDGEYRL | A | West Nile virus NY-99 polyprotein precursor 2023-2031 |
A*02:01 | 1322 | ATWAENIQV | A | West Nile virus NY-99 polyprotein precursor 3390-3398 |
H-2Db | 663 | LGMSNRDFL | A | West Nile Virus polyprotein 294-302 |
(back to top)
ALLELE | PEPTIDE CODE | PEPTIDE SEQUENCE | Stock/ | EPITOPE ORIGIN |
H-2Kb | 1182 | ATLTYRML | A | Yellow Fever Virus 17D polyprotein 268-275 |
